Article: mRNA Development & Manufacturing: CMC Challenges & Solutions
Summary:
The demand for mRNA-based vaccines and treatments has increased significantly, and the industry has been challenged to not only meet these needs, but also improve existing manufacturing processes and efficiencies. Current challenges with mRNA development and manufacturing include a lack of standardization, supply chain challenges, difficulties scaling the process, and the complexity of the molecule itself.